Kim Nathan S, Lam Aaron W, Golub Ivan J, Sheth Bhavya K, Vakharia Rushabh M, Saleh Ahmed, Razi Afshin E
Department of Orthopaedic Surgery, Maimonides Medical Center, Brooklyn, New York, NY, USA.
State University of New York (SUNY) Downstate, School of Medicine, Brooklyn, New York, NY, USA.
Global Spine J. 2023 Jul;13(6):1467-1473. doi: 10.1177/21925682211037265. Epub 2021 Aug 19.
Retrospective study.
To determine whether opioid use disorder (OUD) patients undergoing 1- to 2-level anterior cervical discectomy and fusion (1-2ACDF) have higher rates of: 1) in-hospital lengths of stay (LOS); 2) readmissions; 3) complications; and 4) costs.
OUD patients undergoing primary 1-2ACDF were identified within the Medicare database and matched to a control cohort in a 1:5 ratio by age, sex, and medical comorbidities. The query yielded 80,683 patients who underwent 1-2 ACDF with (n = 13,448) and without (n = 67,235) OUD. Outcomes analyzed included in-hospital LOS, 90-day readmission rates, 90-day medical complications, and costs. Multivariate logistic regression analyses were used to calculate odds-ratios (OR) for medical complications and readmissions. Welch's -test was used to test for significance for LOS and cost between the cohorts. An alpha value less than 0.002 was considered statistically significant.
OUD patients were found to have significantly longer in-hospital LOS compared to their counterparts (3.41 vs. 2.23-days, .0001), in addition to higher frequency and odds of requiring readmissions (21.62 vs. 11.57%; OR: 1.38, .0001). Study group patients were found to have higher frequency and odds of developing medical complications (0.88 vs. 0.19%, OR: 2.80, < .0001) and incurred higher episode of care costs ($20,399.62 vs. $16,812.14, .0001).
The study can help to push orthopaedic surgeons in better managing OUD patients pre-operatively in terms of safe discontinuation and education of opioid drugs and their effects on complications, leading to more satisfactory outcomes.
回顾性研究。
确定接受1至2节段颈椎前路椎间盘切除融合术(1-2ACDF)的阿片类物质使用障碍(OUD)患者是否在以下方面具有更高的发生率:1)住院时间(LOS);2)再入院率;3)并发症;4)费用。
在医疗保险数据库中识别出接受初次1-2ACDF的OUD患者,并按年龄、性别和医疗合并症以1:5的比例与对照组进行匹配。查询得到80683例接受1-2ACDF的患者,其中有OUD的患者(n = 13448)和无OUD的患者(n = 67235)。分析的结果包括住院LOS、90天再入院率、90天医疗并发症和费用。采用多因素逻辑回归分析计算医疗并发症和再入院的比值比(OR)。采用韦尔奇t检验对两组之间的LOS和费用进行显著性检验。α值小于0.002被认为具有统计学显著性。
发现OUD患者的住院LOS明显长于对照组(3.41天对2.23天,P <.0001),此外再入院的频率和几率也更高(21.62%对11.57%;OR:1.38,P <.0001)。研究组患者发生医疗并发症的频率和几率更高(0.88%对0.19%,OR:2.80,P <.0001),且护理费用更高(20399.62美元对16812.14美元,P <.0001)。
该研究有助于促使骨科医生在术前更好地管理OUD患者,包括安全停用阿片类药物以及对其药物及并发症影响的教育,从而带来更满意的结果。